Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer - PubMed (original) (raw)
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer
Ken-ichi Kozaki et al. Cancer Res. 2008.
Abstract
In the last few years, microRNAs (miRNA) have started a revolution in molecular biology and emerged as key players in the carcinogenesis. They have been identified in various tumor types, showing that different sets of miRNAs are usually deregulated in different cancers. To identify the miRNA signature that was specific for oral squamous cell carcinoma (OSCC), we first examined expression profiles of 148 miRNAs in a panel of 18 OSCC cell lines and the immortalized oral keratinocyte line RT7 as a control. Compared with RT7, the expression of 54 miRNAs (36.5%) was frequently down-regulated in OSCC lines (<0.5-fold expression, >or=66.7% of 18 lines). Among these 54 miRNAs, we further analyzed four of these miRNAs (i.e., miR-34b, miR-137, miR-193a, and miR-203), located around CpG islands, to identify tumor-suppressive miRNAs silenced through aberrant DNA methylation. The expression of those four genes was restored by treatment with 5-aza-2'-deoxycytidine in OSCC cells lacking their expression. In addition, expression levels of the four miRNAs were inversely correlated with their DNA methylation status in the OSCC lines. In primary tumors of OSCC with paired normal oral mucosa, down-regulation of miRNA expression through tumor-specific hypermethylation was more frequently observed for miR-137 and miR-193a than for miR-34b and miR-203. Moreover, the ectopic transfection of miR-137 or miR-193a into OSCC lines lacking their expressions significantly reduced cell growth, with down-regulation of the translation of cyclin-dependent kinase 6 or E2F transcription factor 6, respectively. Taken together, our results clearly show that miR-137 and miR-193a are tumor suppressor miRNAs epigenetically silenced during oral carcinogenesis.
Similar articles
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. Furuta M, et al. Carcinogenesis. 2010 May;31(5):766-76. doi: 10.1093/carcin/bgp250. Epub 2009 Oct 20. Carcinogenesis. 2010. PMID: 19843643 - The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J. Uesugi A, et al. Cancer Res. 2011 Sep 1;71(17):5765-78. doi: 10.1158/0008-5472.CAN-11-0368. Epub 2011 Jul 27. Cancer Res. 2011. PMID: 21795477 - Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H, Muramatsu T, Furuta M, Uzawa N, Pimkhaokham A, Amagasa T, Inazawa J, Kozaki K. Endo H, et al. Carcinogenesis. 2013 Mar;34(3):560-9. doi: 10.1093/carcin/bgs376. Epub 2012 Dec 10. Carcinogenesis. 2013. PMID: 23233740 - The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T, Hanazawa T, Nohata N, Okamoto Y, Seki N. Kinoshita T, et al. J Hum Genet. 2012 Sep;57(9):556-63. doi: 10.1038/jhg.2012.75. Epub 2012 Jun 21. J Hum Genet. 2012. PMID: 22718022 Review. - MicroRNAs: new actors in the oral cancer scene.
Wu BH, Xiong XP, Jia J, Zhang WF. Wu BH, et al. Oral Oncol. 2011 May;47(5):314-9. doi: 10.1016/j.oraloncology.2011.03.019. Epub 2011 Apr 6. Oral Oncol. 2011. PMID: 21474366 Review.
Cited by
- miR-137 inhibits renal cell carcinoma growth in vitro and in vivo.
Zhang H, Li H. Zhang H, et al. Oncol Lett. 2016 Jul;12(1):715-720. doi: 10.3892/ol.2016.4616. Epub 2016 May 24. Oncol Lett. 2016. PMID: 27347205 Free PMC article. - Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.
Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ, Lu X, Gross N, Kulesz-Martin M, Wang D, Lu SL. Minor J, et al. Oral Oncol. 2012 Jan;48(1):73-8. doi: 10.1016/j.oraloncology.2011.11.006. Epub 2011 Nov 30. Oral Oncol. 2012. PMID: 22133638 Free PMC article. - The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.
Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Okamoto Y, Seki N. Koshizuka K, et al. J Hum Genet. 2017 Jan;62(1):3-13. doi: 10.1038/jhg.2016.105. Epub 2016 Aug 25. J Hum Genet. 2017. PMID: 27557665 Review. - Differential expression of miRNAs in the serum of patients with high-risk oral lesions.
Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C. Maclellan SA, et al. Cancer Med. 2012 Oct;1(2):268-74. doi: 10.1002/cam4.17. Epub 2012 Jul 19. Cancer Med. 2012. PMID: 23342275 Free PMC article. - The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
Pode-Shakked N, Shukrun R, Mark-Danieli M, Tsvetkov P, Bahar S, Pri-Chen S, Goldstein RS, Rom-Gross E, Mor Y, Fridman E, Meir K, Simon A, Magister M, Kaminski N, Goldmacher VS, Harari-Steinberg O, Dekel B. Pode-Shakked N, et al. EMBO Mol Med. 2013 Jan;5(1):18-37. doi: 10.1002/emmm.201201516. Epub 2012 Dec 13. EMBO Mol Med. 2013. PMID: 23239665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical